While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...
MedPage Today on MSN14d
Have the New Pulmonary Hypertension Drugs Changed the Game?After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...
(Photo source: PTI) Pulmonary hypertension is a complex and poorly understood condition. The exact cause of pulmonary hypertension can vary from patient to patient. According to Dr. Arjun Khanna ...
Stanford University are preparing for a Phase II in Pulmonary Arterial Hypertension (PAH)Kiel, Germany, January 8, 2025 – tiakis ...
Steve Van Wormer has published nearly 500 podcasts about pulmonary hypertension (PH) — more than perhaps anyone working in rare diseases.
Cibotercept is under clinical development by Keros Therapeutics and currently in Phase II for Pulmonary Arterial Hypertension.
Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback